July 26, 2016 12:52 PM ET


Company Overview of CerRx Inc.

Company Overview

CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based in Lubbock, Texas.

9801 Reese Boulevard

Suite 104

Lubbock, TX 79416

United States

Founded in 2008



Key Executives for CerRx Inc.

Chief Executive Officer
Age: 72
Chief Medical Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CerRx Inc., please visit www.cerrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.